Clinical Trial Results:
Double-blind, placebo-controlled trial investigating the safety of re-exposure to 900 mg of Org 34517, used as adjunctive therapy in subjects with psychotic major depression (major depressive episode, severe, with psychotic features), who participated in Trial 28130
Summary
|
|
EudraCT number |
2004-002156-34 |
Trial protocol |
CZ |
Global completion date |
16 Jun 2006
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
No
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
No
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
No
|
Results information
|
|
Results version number |
v2(current) |
This version publication date |
27 Dec 2018
|
First version publication date |
13 Nov 2016
|
Other versions |
v1 |
Version creation reason |
|
Summary report(s) |
EudraCT Summary Results for P05842 |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.